Your session is about to expire
← Back to Search
Motivational Texting for Heart Attack Care
N/A
Recruiting
Led By Dennis Ko, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presentation or admission to Sunnybrook Hospital with diagnosis of Acute Coronary Syndrome (ACS)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within one month, 3 months, and 12 months of hospital discharge
Awards & highlights
Study Summary
This trial will study if texting can help improve care for heart attack patients and reduce hospital readmissions.
Who is the study for?
This trial is for heart attack patients over 18 who were treated at Sunnybrook Hospital, have a cellphone with texting, and can read and respond to English texts. It's not for those who can't consent in English or lack SMS-capable phones.Check my eligibility
What is being tested?
The TEACH pilot trial tests if motivational text messages after hospital discharge can improve care for heart attack patients. Participants are randomly assigned to receive these texts or be in a control group without them.See study design
What are the potential side effects?
Since the intervention involves sending and receiving text messages, there are no direct medical side effects. However, participants may experience stress or anxiety from regular communication about their health condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was admitted to Sunnybrook Hospital with a heart attack or related condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within one month, 3 months, and 12 months of randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within one month, 3 months, and 12 months of randomization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physician visit
Secondary outcome measures
Emergency Department presentation
Medication compliance
Re-hospitalization
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Texting intervention groupExperimental Treatment1 Intervention
Subjects will receive specific health-related texts
Group II: Control groupPlacebo Group1 Intervention
Subjects will receive general text messages without health information
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,058 Total Patients Enrolled
11 Trials studying Coronary Artery Disease
3,947 Patients Enrolled for Coronary Artery Disease
Dennis Ko, MDPrincipal InvestigatorResearch Director
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot give consent in English.I was admitted to Sunnybrook Hospital with a heart attack or related condition.I am older than 18 years.You don't have a cellphone that can send and receive text messages.
Research Study Groups:
This trial has the following groups:- Group 1: Control group
- Group 2: Texting intervention group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor currently recruiting participants?
"Indeed, the records hosted on clinicaltrials.gov show that this trial has been open for recruitment since June 16th 2022 and was recently adjusted on November 16th 2022. 250 individuals must be enrolled at just a single site in order to complete the study's objectives."
Answered by AI
What is the enrollment capacity for this research endeavor?
"Affirmative. As documented on clinicaltrials.gov, this ongoing trial was first posted in mid-June and recently updated in mid-November 2022. The study requires 250 participants from one medical site to participate."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger